Amarantus Bioscience Holdings Inc (AMBS)

[jacmar1965]

Milestones & Catalysts
LymPro
• Pilot clinical performance study (1Q-14);
• Clinical Performance study to support CLIA registra7on (1H-14);
• Commercial Launch as a Laboratory-Developed Test (“LDT”) under CLIA (2H- 2014);
MANF
• Preliminary systemic toxicology (PK/PD rela7onship) (1H-14) • Re7ni7s Pigmentosa: func7onal gene7c mouse model (1H-14) • Re7ni7s Pigmentosa: clinical popula7on selec7on (1H-14) • Parkinson’s disease: CED delivery data w/Renishaw (1H-14)


Any day now, to the moon Alice!!!!